
    
      This is a multi-centre study with three centres participating with a target of 30 to 90
      patients entering the maintenance period and 20-60 patients completing long-term treatment
      per centre. The recruitment period will be about three months from the start of the study.

      Study Hypothesis:

      The primary objective of this study is to demonstrate the long-term safety of a fixed dose
      combination of telmisartan/HCTZ fixed-dose combination treatment. This study has no control
      group; therefore, no hypothesis testing will be performed.

      Comparison(s):

      This study has no control group.
    
  